Abstract
Aldosterone produced by adrenal zona glomerulosa (ZG) cells plays an important role in maintaining salt/water balance and, hence, blood pressure homeostasis. However, when dysregulated, aldosterone advances renal and cardiovascular disease states. Multiple steps in the steroidogenic pathway require Ca2+, and the sustained production of aldosterone depends on maintained Ca2+ entry into the ZG cell. Nevertheless, the recorded membrane potential of isolated ZG cells is extremely hyperpolarized, allowing the opening of only a small fraction of low-voltage-activated Ca2+ channels of the Cav3.x family, the major Ca2+ conductance on the ZG cell membrane. As a consequence, to activate sufficient Ca2+ channels to sustain the production of aldosterone, aldosterone secretagogs would be required to affect large decreases in membrane voltage, a requirement that is inconsistent with the exquisite sensitivity of aldosterone production in vivo to small changes (0.1 mm) in extracellular K+. In this review, we evaluate the contribution of membrane voltage and voltage-dependent Ca2+ channels to the control of aldosterone production and consider data highlighting the electrical excitability of the ZG cell. This intrinsic capacity of ZG cells to behave as electrical oscillators provides a platform from which to generate a recurring Ca2+ signal that is compatible with the lengthy time course of steroidogenesis and provides an alternative model for the physiological regulation of aldosterone production that permits both amplitude and temporal modulation of the Ca2+ signal.
Aldosterone is an important determinant of water and electrolyte balance and, hence, blood pressure homeostasis. Under conditions of restricted dietary sodium or hypovolemia, aldosterone acts via the nuclear mineralocorticoid receptor (MR) to retain sodium (and water) by increasing the capacity of the nephron for Na+ reabsorption. However, when levels of aldosterone are inappropriate for salt status (1), aldosterone advances disease processes, such as cardiac fibrosis, nephrosclerosis, and arteriosclerosis, that pervade the common chronic disease states of congestive heart failure, resistant arterial hypertension, and chronic kidney disease (2–5). Consequently, the addition of an MR antagonist to the standard of care of patients with a diverse disease spectrum [congestive heart failure (6), nonfatal myocardial infarction (7, 8), atrial fibrillation, and resistant hypertension (5, 9)] has been of great therapeutic benefit.
Several mechanisms may mediate the cardiovascular and reno-protective benefits of MR blockade that include: reduced cardiac electrical remodeling (10, 11), diminished myocardial and renal structural hypertrophy with reduced perivascular inflammation and fibrosis (12–14), improved endothelial and baroreceptor function (15), as well as the maintenance of serum K+ and magnesium levels that prevent arrhythmogenesis (16). Although cardiovascular and renal damage have been associated with MR activation, there remains an obligate requirement for dietary salt that is not understood (9, 17, 18). Also, poorly understood are the pathogenic contributions of aldosterone that are independent of MR activation (19), most notably, acute vasoconstrictor events that induce their own damage (19). Therefore, there is strong rationale for exploring therapies that are complementary to MR receptor blockade that directly target the regulation of aldosterone production.
In this minireview, we define and evaluate the contribution of membrane voltage and voltage-dependent Ca2+ channels to the control of aldosterone production. We synthesize old observations with new findings to advance an electrical model of the zona glomerulosa (ZG) cell that emphasizes amplitude and temporal modulation of the Ca2+ signal and that invites the consideration of a broader participation of ionic conductances in the control of aldosterone production (Fig. 1). For models of the ZG cell that emphasize important spatial organization of the Ca2+ signal, we direct the readership to previously published reviews (20, 21).
Fig. 1.
Schematic model of electrically excitable ZG cell. Ang II increases the frequency of membrane potential oscillations in ZG cells, resulting in enhanced Ca2+ entry that acts at multiple sites to promote the production if aldosterone. The ZG electrical response to Ang II stimulation is mediated by the coordinated activities of multiple channel conductances. Transient inhibition of K+ channels via AT1R activation produces a membrane depolarization and the opening of voltage-dependent Ca2+ channels. The activities of high-voltage dependent and/or Ca2+-activated K+ conductances participate in the restoration of baseline Vm, returning Ca2+ channels to a closed state from which they can open during the next oscillatory cycle. Green arrows indicate aldosterone promoting action, whereas red lines indicate basal inhibitory activities.
Hormonal Synergy: Angiotensin II (Ang II) and K+
Aldosterone is produced from the subcapsular layer of the adrenal gland, the ZG, and is the product of the activities of several mixed function oxidases and hydroxylases that are distributed among the cytoplasmic, mitochondrial, and endoplasmic reticular compartments of the cell. Production of this steroid hormone reflects both synthesis and secretion. Aldosterone production is increased by circulating concentrations of its two major secretagogs, Ang II and plasma K+, and is acutely regulated by adrenocorticotropic hormone and locally produced endothelin-1. It is inhibited acutely by circulating atrial natriuretic peptide and tonically by locally produced dopamine (20, 22).
Although Ang II and K+ regulate aldosterone production independently, Ang II synergizes with serum K+ in the rich ionic milieu of plasma with noteworthy consequences. First, low concentrations of either agonist (≤25 pg/ml Ang II; ≤3.0 mm K+) preclude a robust aldosterone response to the other stimulator, with K+ exerting greater regulatory control over the responses elicited by Ang II than the converse. Secondly, when the concentration of Ang II or K+ is modest to high, small changes in the concentration of the other agonist elicit large increases in aldosterone production (23, 24). As a result of this multiplicative interplay, aldosterone production in vivo remains remarkably sensitive to small incremental changes in plasma K+ (0.1 mm) that can be affected by changes in the level of dietary K+ intake (25).
Aldosterone Production: Dependence on Ca2+ and Cav3.2 Ca2+ Currents
Regulation of aldosterone production by Ang II and K+ is Ca2+ dependent; inorganic cations and organic Ca2+ channel antagonists that block Ca2+ entry inhibit stimulated production (26–32). The sites of action of Ca2+ in steroidogenesis are many: 1) Ca2+ increases the activity of cholesterol ester hydrolase, which deesterifies cholesterol to release it from its cytoplasmic storage site (33); 2) Ca2+ increases the cytoskeletal delivery of cholesterol to the outer mitochondrial membrane (34, 35); 3) Ca2+ increases the intramitochondrial transfer of cholesterol to the inner membrane by promoting the transcription and translation of steroidogenic acute regulator protein (35, 36); 4) Ca2+ increases mitochondrial oxidative metabolism and the Ca2+-dependent formation of reduced nicotinamide adenine dinucleotide phosphate, a cofactor required for the activities of P450 cytochromes such as CYP11A1 and CYP11B2 (37, 38); and 5) Ca2+ stimulates the Ca2+/calmodulin kinase I-dependent transcription of CYP11B2, the aldosterone synthase gene product that catalyzes the three-step conversion of 11-deoxycorticosterone to aldosterone (39). Given the importance of Ca2+ to steroidogenesis and the requirement for sustained Ca2+ influx for stimulated production, it is therefore not surprising that modulation of Ca2+ entry into the ZG cell is a formidable way to control the production of aldosterone.
Voltage-gated Ca2+ channels are the major Ca2+-selective conductances that have been identified on the plasma membrane of the ZG cell. Early electrophysiological recordings uniformly described two components of Ca2+ current in rat and bovine ZG cells that could be ascribed to distinct populations of Ca2+ channel classes: low-voltage activated (LVA) (T-type, Cav3.x) and high-voltage activated (HVA) (subfamily L-type, Cav1.x) (40–43). These channel classes differ in their voltage dependence of opening and inactivation (T-type channels require smaller depolarizations from a hyperpolarized baseline to open and inactivate) in their kinetics for closing and inactivation (T-type channels close more slowly but inactivate more rapidly in response to strong depolarizations) and in their susceptibility to modification by dihydropryidines (selective for L-type at low dose) (44). Although there are reported quantitative differences in the expression of T-type and L-type currents among isolated ZG cell preparations (species and conditions of culture), current-voltage relationships derived from whole-cell patch recordings of Ca2+ current generally show current peaking at membrane potentials (Vm) that are approximately 30 mV negative to 0 mV, consistent with a dominance of T-type Ca2+ channel activity (41, 45). However, L-type currents are more susceptible to rundown and Ca2+-induced inactivation and, thus, may be underestimated.
Among the three Cav3.x family members, Cav3.2 channels are the predominant subtype expressed in ZG cells across species as determined by quantitative RT-PCR, in situ hybridization (46, 47), and high-affinity inhibition of ZG Ca2+ current by nickel (IC50, 5–20 μm for Cav3.2 vs. 200–300 μm for Cav3.1 or 3.3) (48). Among the members of the Cav1.x family, mRNA for Cav1.2 (α1C) and Cav1.3 (α1D) channels is expressed in ZG cells (47, 49) in agreement with high-affinity inhibition of ZG HVA current by dihydropyridines.
The relative contribution of T-type vs. L-type Ca2+ channels to the sustained production of aldosterone has been debated. Several lines of evidence support a primary role for T-type channels as the principal Ca2+ influx pathway activated by physiological concentrations of Ang II and K+. First, because the voltage-range over which Cav3.2 channels activate and inactivate overlaps, Cav3.2 channels can carry steady-state (window) currents within a voltage range that parallels and can account for the biphasic dependence of aldosterone secretion on extracellular K+ (42). Second, in perforated patch-clamp recordings in which the intracellular milieu of the cell is not disrupted, low physiological concentrations of Ang II (0.1 to 1 nm) that markedly increase aldosterone production elicit slow depolarizing responses (6–12 mV) that may be sufficient to activate a small proportion of T-type but not L-type Ca2+ channels. In contrast, supraphysiologic concentrations of Ang II or K+ that induce large maintained depolarizations of adequate magnitude (30–40 mV) to drive T-type Ca2+ channel inactivation to completion elicit only modest increases in aldosterone production (45, 50). Third, block of L-type Ca2+ channel currents by ω-agatoxin IIIA or their inhibition by Ang II fails to decrease the steroidogenic response to physiological concentrations of K+ or Ang II (45, 51), whereas the activation of these currents and the ensuing large rise in cytosolic Ca2+ that is produced actually inhibits aldosterone biosynthesis (37, 51, 52).
ZG Cell: A Model Nonexcitable Cell?
The ZG cell does not express fast Na+ channels and thus does not fire Na+-dependent action potentials. Rather, in physiological, asymmetrical K+ solutions, the ZG Vm follows closely the predicted equilibrium potential for K+ over a broad range of extracellular K+ concentrations (4–28 mm). Nevertheless, because the Vm of ZG cells is more depolarized than EK (dependence less than 58.8 mV/10-fold change in K and especially so <4 mm K+) (45, 53), the ZG membrane at rest is not exclusively K+ permeable; rather a persistent depolarizing conductance(s) must also be active. A likely candidate for this conductance is a Ca2+-permeable nonselective cation channel previously identified in rat ZG cells (54). An unlikely candidate is Cav3.2 channels, because there is uniform agreement that the Vm of unstimulated ZG cells (at 3.5 mm K+) is negative to −78 mV (−78 to −90 mV) (50, 53, 55), at which the open probability of LVA Ca2+ channels is extremely low (50, 56). Therefore, Cav3.2 channels in ZG cells are predicted to be mainly closed at rest but available for opening upon membrane depolarization. Hence, sustained inhibition of a dominant background K+ conductance is required of aldosterone secretagogs to move the Vm of ZG cells into a voltage range where steady-state Ca2+ entry through Cav3.2 channels is probable.
Several voltage-gated K+ conductances have been identified in ZG cells, although their expression varies across species and with the conditions of cell culture (20, 55). These include a delayed rectifier (57, 58), a transient A-type current [dominant in bovine (57, 58) and human (43) ZG], a slow delayed rectifier (43, 59, 60), an outward rectifier (55), and a Ca2+-dependent maxi-K+-type current (Table 1) (43, 55, 58, 61). However, collective analyses of these voltage-dependent conductances suggest that they are not likely to be active at the hyperpolarized resting Vm of ZG cells, and thus, although inhibited by Ang II, they are not suitable to initiate the depolarizing action that is required of aldosterone secretagogs. By contrast, two background K+ currents have been identified in ZG cells: inward rectifier (58, 62) and leak K+ currents (61, 63–65). However, at negative resting membrane voltages, only leak K+ currents have been recorded at both the single channel and macroscopic levels (55, 64). This contrasts with the early recording of “inwardly rectifying” single-channel currents (58) that originally were attributed to an inward rectifier, but for which no macroscopic correlate of current could be identified, raising the possibility that the subsequently identified nonselective cation channel (54, 66) may have been responsible for these currents.
Table 1.
K+ conductances in ZG cells
| Channel type/current | Properties | K+ channel family | Species | Inhibition |
|---|---|---|---|---|
| Delayed rectifier (IK) | Slowly voltage activated/slowly voltage inactivating or noninactivating | ? | Rat (57, 58) | Ang ll |
| Human (57) | Ang II | |||
| Slow delayed rectifier (IKs) | Very slowly voltage activated/noninactivating | Kv7.1 | Mouse (60) | |
| ? | Human (43) | |||
| ? | Rat (59) | |||
| Outward rectifying | Rapidly voltage activated/noninactivating | ? | Rat (55) | |
| A-type K+ channel (IA) | Rapidly voltage activated/rapidly voltage inactivating | ? | Bovine (57, 58) | Ang II |
| ? | Human (43) | Ang II | ||
| Maxi K (BK) | Ca2+ and voltage activated | KCa1.1 | Rat (55, 58, 61) | Ang II |
| Small K (SKCa) | Ca2+/CaM activated | Bovine (58) | ||
| Human (43) | Ang II | |||
| KCa2.2 | Rat (77) | |||
| Leak K (Ileak) | Weakly voltage activated/noninactivating | TASK-1/3 | Rat (61, 63, 64) | Ang II/[H+]o |
| Mouse (65) | Ang II/[H+]o | |||
| TREK-1 | Bovine (76) | Ang II | ||
| Inward rectifier (IIRK) | Gβγ activated/voltage inactivating | Kir3.4 | Human (62) | |
| ? | Rat (58) | Ang ll | ||
| ? | Bovine (58) | Ang II |
Summary of reported K+ conductances in ZG cells of various species. ? indicates the molecular correlate is not identified.
Nevertheless, it is of note that mutations in or close to the selectivity filter of the G protein-activated inward rectifier K+ channel (Kir3.4) are found in a subset (36–41%) of aldosterone-producing adenomas (62, 67). Heterologous expression of these mutant channels in model cells results in loss of K+ selectivity, commensurate with an increase in Na+ conductance to produce membrane depolarization, and in model adrenal cells (HAC-15) an elevation in aldosterone production (62, 68). Taken together, these studies provide proof of principal for the importance of inward rectifier currents in the modulation of aldosterone production in tumorigenic ZG cell function.
The KCNK background (“leak”) K+ channel family is encoded by multiple genes that are grouped into seven subfamilies. These channels show little or no voltage dependence and thus generate background K+ currents that play a major role in setting negative resting membrane voltages. Functional channels are formed by the dimeric association of subunits that contain two-pore and four transmembrane spanning domains (2P/4TM). Two family members, TWIK-related acid-sensitive K+ (TASK) channel TASK-1 and TASK-3 subunits, are abundantly expressed in the ZG layer (rat, mouse, and human) (63–65), allowing the potential for homo- and heteromeric TASK channel conformations (69). The combined deletion of TASK-1 and TASK-3 subunits from mouse ZG cells results in an approximately 20-mV baseline membrane depolarization and markedly increases (400%) aldosterone production (65, 70). Although the pharmacological characterization of gKleak in rat recapitulates properties of TASK-3 homomeric channels, the IC50 for pH inhibition (pH 7.5) is not in agreement with that of TASK-3 channels (pH 6.8) (64), nor does the sole deletion of TASK-3 subunits from mouse ZG cells result in a baseline membrane depolarization (70). Therefore, the subunit composition of native ZG channels remains unresolved. Nevertheless, in either homo- or heteromeric configuration, the activation of Gq-coupled receptors induces an inhibition of TASK channel activity. Thus, the inhibition of ZG TASK channels by Ang II is predicted to induce a passive analog shift in voltage that removes the restraint on aldosterone production. However, under physiological conditions, whether at rest or during stimulation with Ang II or K+, the elicited depolarization is small (4–10 mV from baseline) and the Vm remains in a range where steady-state Ca2+ entry is very low. As a consequence, mechanisms which modify Cav3.2 channel gating by shifting the voltage dependence of channel opening will increase (hyperpolarized shift) or decrease (depolarized shift) steady-state Ca2+ entry and hence contribute to the control of aldosterone production. Of note, phosphorylation of the II–III linker of Cav3.2 channels by Ca2+/calmodulin (CaM)-dependent kinase II induces a 10-mV hyperpolarizing shift, or by Rho-associated kinase, a 10-mV depolarizing shift, in the voltage dependence for half-activation of Cav3.2 channels to elicit opposing changes in Ca2+ entry.
The ZG Cell: A Model Excitable Cell?
The earliest sharp microelectrode recordings of “peripheral” cells (ZG) in cat adrenal slices showed rapid spontaneous fluctuations in Vm in a percentage of impaled cells and “spike potentials” that were evoked by Ang II or K+ in most others (71). This hint of electrical excitability was reanalyzed in dissociated/cultured ZG cell preparations in the mid-1980s. Although isolated ZG cells showed no spontaneous spiking activity, Ca2+-dependent Vm fluctuations could be evoked by depolarizing current injection and/or pharmacological blockade of outward K+ currents (72). Active responses also have been measured in acutely dissociated cells using the patch-clamp technique. Superimposed on larger analog shifts in membrane voltage, Ang II evoked small depolarizing membrane potential fluctuations. These active responses were almost certainly curtailed by the recording protocol that repetitively delivered hyperpolarizing current to permit the concurrent measurement of membrane resistance (45).
Taken together, these data are inconsistent with the accepted dogma of ZG cell nonexcitability and provided the impetus for our laboratory to determine the membrane properties of ZG cells retained within an acute adrenal slice (47). We find that mouse ZG cells in adrenal slices act as electrical oscillators, showing both a voltage-threshold and a voltage dependence to their oscillatory activity. ZG Vm oscillations are spontaneous, large (deviating ∼70 mV from baseline Vm), of low periodicity (∼2 sec), and are modulated in frequency by Ang II and K+. Notably, these oscillations provide a platform from which to generate a significant and recurring steady-state Ca2+ signal that is compatible with the lengthy time course of steroid hormone production (minutes-hours) and that can be fine-tuned by aldosterone secretagogs. This innate capacity of the ZG cell to behave as an electrical oscillator may provide a novel and/or alternative molecular explanation for: 1) the oscillatory character of cytosolic Ca2+ signaling in ZG cells evoked by physiological concentrations of Ang II; 2) the requirement for a large depolarization from a baseline voltage of approximately −90 mV to activate even LVA Ca2+ channels; 3) the generation of high-Ca2+ microdomains that are necessary for the efficient transfer of Ca2+ into the mitochondria by the low-Ca2+ affinity mitochondrial uniporter; and 4) the hyperaldosteronism (60) that is produced by the deletion of the KCNE1 subunit in mice (the regulatory subunit of a voltage activated KCNQ1 K+ channel, with a voltage of half-activation equal to 5 mV).
Recognition of the intrinsic capacity of ZG cells to generate rhythmic electrical signals provides not only a novel/alternative way to understand the diverse set of previously mentioned signaling incongruities but also may serve to broaden our perspective of cellular response elements that contribute to the regulation of aldosterone production. For example, oscillations in membrane voltage allow for the full complement of K+ conductances previously identified in ZG cells to participate in the regulation of steroidogenesis. As a consequence, when viewed in the context of an excitable cell, TASK channels will retain their singular importance during the depolarization phase of the oscillatory cycle when membrane voltage is highly negative by affecting the rate of depolarization between spikes, whereas delayed rectifiers and BK channels will play a more dominant role during the later phases of the oscillatory cycle when membrane voltage is depolarized by controlling the rate of repolarization. Notably, this shared importance is supported by mouse models of human disease, in which the combined genetic deletion of TASK-1 and TASK-3 subunits (65, 70) or KCNE1 (60) subunits results in hyperaldosteroinsm. By analogy, although substantial data support a role for Cav3.2 channels in the control of steroid hormone production, in the excitable ZG cell, HVA Ca2+ channels of the Cav1.x family unquestionably are activated, raising the possibility that as in subsets of neurons, these channels may support an alternate function, that of modulating gene transcription (73).
Finally, an excitable ZG cell is a cell that allows for nuanced steroid hormone regulation: a change in intracellular response can be achieved by either amplitude or temporal modulation of the Ca2+ signal, the former involving a change in the concentration of Ca2+, the latter involving a change in pulsatility or oscillation frequency. It is noteworthy, therefore, that frequency decoding of the Ca2+ signal is a property of a subclass of CaM-dependent effectors, Ca2+/CaM-dependent protein kinase I and II, that can accumulate, and thus integrate, activity in response to pulsatile Ca2+ signals (74, 75). Given the importance of these kinases at multiple steps in aldosterone biosynthesis, they may be at the very heart of information transfer in the excitable ZG cell coordinating the flow of information from the cell surface to the cell interior to control both the short- and long-term production of aldosterone.
Acknowledgments
This work was supported by National Institutes of Health Grants HL-089717 and HL-036977 (to P.Q.B.).
Disclosure Summary: The authors have nothing to disclose.
Footnotes
- Ang II
- Angiotensin II
- CaM
- calmodulin
- HVA
- high-voltage activated
- LVA
- low-voltage activated
- MR
- mineralocorticoid receptor
- TASK
- TWIK-related acid-sensitive potassium channel
- Vm
- membrane potential
- ZG
- zona glomerulosa.
References
- 1. Dluhy RG, Williams GH. 2004. Aldosterone—villain or bystander? N Engl J Med 351:8–10 [DOI] [PubMed] [Google Scholar]
- 2. Williams GH. 2005. Aldosterone and heart failure: the rest of the story. Heart Fail Rev 10:5–6 [DOI] [PubMed] [Google Scholar]
- 3. Williams GH. 2005. Aldosterone biosynthesis, regulation, and classical mechanism of action. Heart Fail Rev 10:7–13 [DOI] [PubMed] [Google Scholar]
- 4. Cohn JN, Colucci W. 2006. Cardiovascular effects of aldosterone and post-acute myocardial infarction pathophysiology. Am J Cardiol 97:4F–12F [DOI] [PubMed] [Google Scholar]
- 5. Schiffrin EL. 2006. Effects of aldosterone on the vasculature. Hypertension 47:312–318 [DOI] [PubMed] [Google Scholar]
- 6. Pitt B, Reichek N, Willenbrock R, Zannad F, Phillips RA, Roniker B, Kleiman J, Krause S, Burns D, Williams GH. 2003. Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study. Circulation 108:1831–1838 [DOI] [PubMed] [Google Scholar]
- 7. Epstein M. 2003. Aldosterone receptor blockade and the role of eplerenone: evolving perspectives. Nephrol Dial Transplant 18:1984–1992 [DOI] [PubMed] [Google Scholar]
- 8. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. 1999. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators. N Engl J Med 341:709–717 [DOI] [PubMed] [Google Scholar]
- 9. Calhoun DA. 2006. Use of aldosterone antagonists in resistant hypertension. Prog Cardiovasc Dis 48:387–396 [DOI] [PubMed] [Google Scholar]
- 10. MacFadyen RJ, Barr CS, Struthers AD. 1997. Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients. Cardiovasc Res 35:30–34 [DOI] [PubMed] [Google Scholar]
- 11. Ouvrard-Pascaud A, Sainte-Marie Y, Bénitah JP, Perrier R, Soukaseum C, Nguyen Dinh Cat A, Royer A, Le Quang K, Charpentier F, Demolombe S, Mechta-Grigoriou F, Beggah AT, Maison-Blanche P, Oblin ME, Delcayre C, Fishman GI, Farman N, Escoubet B, Jaisser F. 2005. Conditional mineralocorticoid receptor expression in the heart leads to life-threatening arrhythmias. Circulation 111:3025–3033 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Rocha R, Rudolph AE, Frierdich GE, Nachowiak DA, Kekec BK, Blomme EA, McMahon EG, Delyani JA. 2002. Aldosterone induces a vascular inflammatory phenotype in the rat heart. Am J Physiol Heart Circ Physiol 283:H1802–H1810 [DOI] [PubMed] [Google Scholar]
- 13. Rocha R, Stier CT., Jr 2001. Pathophysiological effects of aldosterone in cardiovascular tissues. Trends Endocrinol Metab 12:308–314 [DOI] [PubMed] [Google Scholar]
- 14. Rocha R, Stier CT, Jr, Kifor I, Ochoa-Maya MR, Rennke HG, Williams GH, Adler GK. 2000. Aldosterone: a mediator of myocardial necrosis and renal arteriopathy. Endocrinology 141:3871–3878 [DOI] [PubMed] [Google Scholar]
- 15. Farquharson CA, Struthers AD. 2002. Aldosterone induces acute endothelial dysfunction in vivo in humans: evidence for an aldosterone-induced vasculopathy. Clin Sci 103:425–431 [DOI] [PubMed] [Google Scholar]
- 16. Williams GH. 2005. Cardiovascular benefits of aldosterone receptor antagonists: what about potassium? Hypertension 46:265–266 [DOI] [PubMed] [Google Scholar]
- 17. Williams GH, Tuck ML, Rose LI, Dluhy RG, Underwood RH. 1972. Studies of the control of plasma aldosterone concentration in normal man. 3. Response to sodium chloride infusion. J Clin Invest 51:2645–2652 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Martinez DV, Rocha R, Matsumura M, Oestreicher E, Ochoa-Maya M, Roubsanthisuk W, Williams GH, Adler GK. 2002. Cardiac damage prevention by eplerenone: comparison with low sodium diet or potassium loading. Hypertension 39:614–618 [PubMed] [Google Scholar]
- 19. Funder JW. 2005. The nongenomic actions of aldosterone. Endocr Rev 26:313–321 [DOI] [PubMed] [Google Scholar]
- 20. Spät A, Hunyady L. 2004. Control of aldosterone secretion: a model for convergence in cellular signaling pathways. Physiol Rev 84:489–539 [DOI] [PubMed] [Google Scholar]
- 21. Rossier MF, Capponi AM. 2002. Cytosolic calcium oscillations in signal transduction pathways. Mini-Rev Med Chem 2:353–360 [DOI] [PubMed] [Google Scholar]
- 22. Quinn SJ, Williams GH. 1988. Regulation of aldosterone secretion. Annu Rev Physiol 50:409–426 [DOI] [PubMed] [Google Scholar]
- 23. Young DB, Smith MJ, Jr, Jackson TE, Scott RE. 1984. Multiplicative interaction between angiotensin II and K concentration in stimulation of aldosterone. Am J Physiol 247:E328–E335 [DOI] [PubMed] [Google Scholar]
- 24. Himathongkam T, Dluhy RG, Williams GH. 1975. Potassim-aldosterone-renin interrelationships. J Clin Endocrinol Metab 41:153–159 [DOI] [PubMed] [Google Scholar]
- 25. Linde R, Winn S, Latta D, Hollifield J. 1981. Graded dose effects of angiotensin II on aldosterone production in man during various levels of potassium intake. Metabolism 30:549–553 [DOI] [PubMed] [Google Scholar]
- 26. Aguilera G, Catt KJ. 1986. Participation of voltage-dependent calcium channels in the regulation of adrenal glomerulosa function by angiotensin II and potassium. Endocrinology 118:112–118 [DOI] [PubMed] [Google Scholar]
- 27. Capponi AM, Lew PD, Jornot L, Vallotton MB. 1984. Correlation between cytosolic free Ca2+ and aldosterone production in bovine adrenal glomerulosa cells. Evidence for a difference in the mode of action of angiotensin II and potassium. J Biol Chem 259:8863–8869 [PubMed] [Google Scholar]
- 28. Cozza EN, Gomez-Sanchez CE. 1993. Mechanisms of ET-1 potentiation of angiotensin II stimulation of aldosterone production. Am J Physiol 265:E179–E183 [DOI] [PubMed] [Google Scholar]
- 29. Fakunding JL, Catt KJ. 1980. Dependence of aldosterone stimulation in adrenal glomerulosa cells on calcium uptake: effects of lanthanum nd verapamil. Endocrinology 107:1345–1353 [DOI] [PubMed] [Google Scholar]
- 30. Hausdorff WP, Aguilera G, Catt KJ. 1986. Selective enhancement of angiotensin II- and potassium-stimulated aldosterone secretion by the calcium channel agonist BAY K 8644. Endocrinology 118:869–874 [DOI] [PubMed] [Google Scholar]
- 31. Kojima K, Kojima I, Rasmussen H. 1984. Dihydropyridine calcium agonist and antagonist effects on aldosterone secretion. Am J Physiol 247:E645–E650 [DOI] [PubMed] [Google Scholar]
- 32. Barrett PQ, Bollag WB, Isales CM, McCarthy RT, Rasmussen H. 1989. Role of calcium in angiotensin II-mediated aldosterone secretion. Endocr Rev 10:496–518 [DOI] [PubMed] [Google Scholar]
- 33. Cherradi N, Pardo B, Greenberg AS, Kraemer FB, Capponi AM. 2003. Angiotensin II activates cholesterol ester hydrolase in bovine adrenal glomerulosa cells through phosphorylation mediated by p42/p44 mitogen-activated protein kinase. Endocrinology 144:4905–4915 [DOI] [PubMed] [Google Scholar]
- 34. Cherradi N, Rossier MF, Vallotton MB, Capponi AM. 1996. Calcium stimulates intramitochondrial cholesterol transfer in bovine adrenal glomerulosa cells. J Biol Chem 271:25971–25975 [DOI] [PubMed] [Google Scholar]
- 35. Cherradi N, Rossier MF, Vallotton MB, Timberg R, Friedberg I, Orly J, Wang XJ, Stocco DM, Capponi AM. 1997. Submitochondrial distribution of three key steroidogenic proteins (steroidogenic acute regulatory protein and cytochrome p450scc and 3β-hydroxysteroid dehydrogenase isomerase enzymes) upon stimulation by intracellular calcium in adrenal glomerulosa cells. J Biol Chem 272:7899–7907 [DOI] [PubMed] [Google Scholar]
- 36. Clark BJ, Pezzi V, Stocco DM, Rainey WE. 1995. The steroidogenic acute regulatory protein is induced by angiotensin II and K+ in H295R adrenocortical cells. Mol Cell Endocrinol 115:215–219 [DOI] [PubMed] [Google Scholar]
- 37. Rossier MF, Burnay MM, Brandenburger Y, Cherradi N, Vallotton MB, Capponi AM. 1996. Sources and sites of action of calcium in the regulation of aldosterone biosynthesis. Endocr Res 22:579–588 [DOI] [PubMed] [Google Scholar]
- 38. Wiederkehr A, Szanda G, Akhmedov D, Mataki C, Heizmann CW, Schoonjans K, Pozzan T, Spät A, Wollheim CB. 2011. Mitochondrial matrix calcium is an activating signal for hormone secretion. Cell Metab 13:601–611 [DOI] [PubMed] [Google Scholar]
- 39. Condon JC, Pezzi V, Drummond BM, Yin S, Rainey WE. 2002. Calmodulin-dependent kinase I regulates adrenal cell expression of aldosterone synthase. Endocrinology 143:3651–3657 [DOI] [PubMed] [Google Scholar]
- 40. Matsunaga H, Maruyama Y, Kojima I, Hoshi T. 1987. Transient Ca2+-channel current characterized by a low-threshold voltage in zona glomerulosa cells of rat adrenal cortex. Pflugers Arch 408:351–355 [DOI] [PubMed] [Google Scholar]
- 41. Durroux T, Gallo-Payet N, Payet MD. 1988. Three components of the calcium current in cultured glomerulosa cells from rat adrenal gland. J Physiol 404:713–729 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Cohen CJ, McCarthy RT, Barrett PQ, Rasmussen H. 1988. Ca channels in adrenal glomerulosa cells: K+ and angiotensin II increase T-type Ca channel current. Proc Natl Acad Sci USA 85:2412–2416 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Payet MD, Durroux T, Bilodeau L, Guillon G, Gallo-Payet N. 1994. Characterization of K+ and Ca2+ ionic currents in glomerulosa cells from human adrenal glands. Endocrinology 134:2589–2598 [DOI] [PubMed] [Google Scholar]
- 44. Nowycky MC, Fox AP, Tsien RW. 1985. Three types of neuronal calcium channel with different calcium agonist sensitivity. Nature 316:440–443 [DOI] [PubMed] [Google Scholar]
- 45. Lotshaw DP. 2001. Role of membrane depolarization and T-type Ca2+ channels in angiotensin II and K+ stimulated aldosterone secretion. Mol Cell Endocrinol 175:157–171 [DOI] [PubMed] [Google Scholar]
- 46. Schrier AD, Wang H, Talley EM, Perez-Reyes E, Barrett PQ. 2001. α1H T-type Ca2+ channel is the predominant subtype expressed in bovine and rat zona glomerulosa. Am J Physiol Cell Physiol 280:C265–C272 [DOI] [PubMed] [Google Scholar]
- 47. Hu C, Rusin C, Tan Z, Guagliardo NA, Barrett PQ. 1 May 2012. Zona glomerulosa cells of the mouse adrenal cortex are intrinsic electrical oscillators. J Clin Invest 10.1171/JCI61996 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Lee JH, Gomora JC, Cribbs LL, Perez-Reyes E. 1999. Nickel block of three cloned T-type calcium channels: low concentrations selectively block α1H. Biophys J 77:3034–3042 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Szabadkai G, Horváth A, Spat A, Enyedi P. 1998. Expression of voltage-dependent calcium channel α1 subunits in rat adrenal capsular tissue and single glomerulosa cells. Endocr Res 24:425–426 [DOI] [PubMed] [Google Scholar]
- 50. Chen XL, Bayliss DA, Fern RJ, Barrett PQ. 1999. A role for T-type Ca2+ channels in the synergistic control of aldosterone production by ANG II and K+. Am J Physiol 276:F674–F683 [DOI] [PubMed] [Google Scholar]
- 51. Barrett PQ, Ertel EA, Smith MM, Nee JJ, Cohen CJ. 1995. Voltage-gated calcium currents have two opposing effects on the secretion of aldosterone. Am J Physiol 268:C985–C992 [DOI] [PubMed] [Google Scholar]
- 52. Python CP, Laban OP, Rossier MF, Vallotton MB, Capponi AM. 1995. The site of action of Ca2+ in the activation of steroidogenesis: studies in Ca(2+)-clamped bovine adrenal zona-glomerulosa cells. Biochem J 305(Pt 2):569–576 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53. Quinn SJ, Cornwall MC, Williams GH. 1987. Electrical properties of isolated rat adrenal glomerulosa and fasciculata cells. Endocrinology 120:903–914 [DOI] [PubMed] [Google Scholar]
- 54. Lotshaw DP, Li F. 1996. Angiotensin II activation of Ca(2+)-permeant nonselective cation channels in rat adrenal glomerulosa cells. Am J Physiol 271:C1705–C1715 [DOI] [PubMed] [Google Scholar]
- 55. Lotshaw DP. 1997. Characterization of angiotensin II-regulated K+ conductance in rat adrenal glomerulosa cells. J Membr Biol 156:261–277 [DOI] [PubMed] [Google Scholar]
- 56. Perez-Reyes E. 2003. Molecular physiology of low-voltage-activated t-type calcium channels. Physiol Rev 83:117–161 [DOI] [PubMed] [Google Scholar]
- 57. Brauneis U, Vassilev PM, Quinn SJ, Williams GH, Tillotson DL. 1991. ANG II blocks potassium currents in zona glomerulosa cells from rat, bovine, and human adrenals. Am J Physiol 260:E772–E779 [DOI] [PubMed] [Google Scholar]
- 58. Vassilev PM, Kanazirska MV, Quinn SJ, Tillotson DL, Williams GH. 1992. K+ channels in adrenal zona glomerulosa cells. I. Characterization of distinct channel types. Am J Physiol 263:E752–E759 [DOI] [PubMed] [Google Scholar]
- 59. Payet MD, Benabderrazik M, Gallo-Payet N. 1987. Excitation-secretion coupling: ionic currents in glomerulosa cells: effects of adrenocorticotropin and K+ channel blockers. Endocrinology 121:875–882 [DOI] [PubMed] [Google Scholar]
- 60. Arrighi I, Bloch-Faure M, Grahammer F, Bleich M, Warth R, Mengual R, Drici MD, Barhanin J, Meneton P. 2001. Altered potassium balance and aldosterone secretion in a mouse model of human congenital long QT syndrome. Proc Natl Acad Sci USA 98:8792–8797 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61. Lotshaw DP. 1997. Effects of K+ channel blockers on K+ channels, membrane potential, and aldosterone secretion in rat adrenal zona glomerulosa cells. Endocrinology 138:4167–4175 [DOI] [PubMed] [Google Scholar]
- 62. Choi M, Scholl UI, Yue P, Björklund P, Zhao B, Nelson-Williams C, Ji W, Cho Y, Patel A, Men CJ, Lolis E, Wisgerhof MV, Geller DS, Mane S, Hellman P, Westin G, Åkerström G, Wang W, Carling T, Lifton RP. 2011. K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science 331:768–772 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63. Czirják G, Enyedi P. 2002. TASK-3 dominates the background potassium conductance in rat adrenal glomerulosa cells. Mol Endocrinol 16:621–629 [DOI] [PubMed] [Google Scholar]
- 64. Lotshaw DP. 2006. Biophysical and pharmacological characteristics of native two-pore domain TASK channels in rat adrenal glomerulosa cells. J Membr Biol 210:51–70 [DOI] [PubMed] [Google Scholar]
- 65. Davies LA, Hu C, Guagliardo NA, Sen N, Chen X, Talley EM, Carey RM, Bayliss DA, Barrett PQ. 2008. TASK channel deletion in mice causes primary hyperaldosteronism. Proc Natl Acad Sci USA 105:2203–2208 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66. Durroux T, Gallo-Payet N, Bilodeau L, Payet MD. 1992. Background calcium permeable channels in glomerulosa cells from adrenal gland. J Membr Biol 129:145–153 [DOI] [PubMed] [Google Scholar]
- 67. Azizan EA, Murthy M, Stowasser M, Gordon R, Kowalski B, Xu S, Brown MJ, O'Shaughnessy KM. 2012. Somatic mutations affecting the selectivity filter of KCNJ5 are frequent in 2 large unselected collections of adrenal aldosteronomas. Hypertension 59:587–591 [DOI] [PubMed] [Google Scholar]
- 68. Oki K, Plonczynski MW, Luis Lam M, Gomez-Sanchez EP, Gomez-Sanchez CE. 2012. Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis. Endocrinology 153:1774–1782 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69. Czirják G, Enyedi P. 2002. Formation of functional heterodimers between the TASK-1 and TASK-3 two-pore domain potassium channel subunits. J Biol Chem 277:5426–5432 [DOI] [PubMed] [Google Scholar]
- 70. Guagliardo NA, Yao J, Hu C, Schertz EM, Tyson DA, Carey RM, Bayliss DA, Barrett PQ. 2012. TASK-3 channel deletion in mice recapitulates low-renin essential hypertension. Hypertension 59:999–1005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71. Natke E, Jr, Kabela E. 1979. Electrical responses in cat adrenal cortex: possible relation to aldosterone secretion. Am J Physiol 237:E158–E162 [DOI] [PubMed] [Google Scholar]
- 72. Quinn SJ, Cornwall MC, Williams GH. 1987. Electrophysiological responses to angiotensin II of isolated rat adrenal glomerulosa cells. Endocrinology 120:1581–1589 [DOI] [PubMed] [Google Scholar]
- 73. Gomez-Ospina N, Tsuruta F, Barreto-Chang O, Hu L, Dolmetsch R. 2006. The C terminus of the L-type voltage-gated calcium channel Ca(V)1.2 encodes a transcription factor. Cell 127:591–606 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74. Schulman H, Hanson PI, Meyer T. 1992. Decoding calcium signals by multifunctional CaM kinase. Cell Calcium 13:401–411 [DOI] [PubMed] [Google Scholar]
- 75. Dosemeci A, Albers RW. 1996. A mechanism for synaptic frequency detection through autophosphorylation of CaM kinase II. Biophys J 70:2493–2501 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76. Enyeart JA, Danthi SJ, Enyeart JJ. 2004. TREK-1 K+ channels couple angiotensin II receptors to membrane depolarization and aldosterone secretion in bovine adrenal glomerulosa cells. Am J Physiol Endocrinol Metab 287:E1154–E1165 [DOI] [PubMed] [Google Scholar]
- 77. Nishimoto K, Rigsby C, Wang T, Mukai K, Gomez-Sanchez C, Rainey W, Seki T. 2010. Transcriptome analysis reveals differentially expressed transcripts in rat adrenal zona glomerulosa and zona fasciculata. Endocrinology 153:1755–1763 [DOI] [PMC free article] [PubMed] [Google Scholar]

